Amanote Research
Register
Sign In
Orphan Designation: Hydroxy-Propyl-Beta-Cyclodextrin, Treatment of Niemann-Pick Disease, Type C
Case Medical Research
doi 10.31525/cmr-da7a89
Full Text
Open PDF
Abstract
Available in
full text
Date
March 15, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Endogenous and Synthetic Neurosteroids in Treatment of Niemann–Pick Type C Disease
Brain Research Reviews
Cyclodextrin Triggers McOLN1-dependent Endo-Lysosome Secretion in Niemann-Pick Type C Cells
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
Characterization of Hydroxypropyl-Beta-Cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1
PLoS ONE
Multidisciplinary
The Spectrum of Niemann-Pick Type C Disease in Greece
JIMD Reports
Internal Medicine
Genetics
Molecular Biology
Biochemistry
Endocrinology
Metabolism
Diabetes
Correction: Characterization of Hydroxypropyl-Beta-Cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1
PLoS ONE
Multidisciplinary
Niemann-Pick Disease
Turkish Journal of Haematology
Hematology
Niemann-Pick Disease, Type C1 (NPC1)
Science-Business eXchange
Niemann–Pick Type C Pathogenesis and Treatment: From Statins to Sugars
Clinical Lipidology
Niemann-Pick Type C Disease: Molecular Mechanisms and Potential Therapeutic Approaches
Journal of Neurochemistry
Biochemistry
Molecular Neuroscience
Cellular